13-2-3　ⓔ文献

  1. Poddubnyy D, Sieper J: Current unmet needs in spondyloarthritis. Curr Rheumatol Rep, 2019; 21: 43.

  2. Rudwaleit M, Landewé R, et al: The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis, 2009; 68: 770–776.

  3. Rudwaleit M, van der Heijde D, et al: The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis, 2011; 70: 25–31.

  4. Kataria RK, Brent LH: Spondyloarthropathies. Am Fam Physician, 2004; 69: 2853–2860.

  5. Raychaudhuri SP, Deodhar A: The classification and diagnostic criteria of ankylosing spondylitis. J Autoimmun, 2014; 48-49: 128–133.

  6. Nguyen MT, Borchers A, et al: The SAPHO syndrome. Semin Arthritis Rheum, 2012; 42: 254–265.

  7. Bettencourt BF, Rocha FL, et al: Protective effect of an ERAP1 haplotype in ankylosing spondylitis: investigating non–MHC genes in HLA–B27–positive individuals. Rheumatology (Oxford), 2013; 52: 2168–2176.

  8. 強直性脊椎炎 (指定難病271)，難病情報センター．

  9. 乾癬性関節炎，リウマチ情報センター．

  10. Hannu T: Reactive arthritis. Best Pract Res Clin Rheumatol, 2011; 25: 347–357.

  11. Eder L, Chandran V, et al: Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Ann Rheum Dis, 2012; 71: 50–55.

  12. Reveille JD, Arnett FC: Spondyloarthritis: update on pathogenesis and management. Am J Med, 2005; 118: 592–603.

  13. Zochling J, Brandt J, et al: The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology (Oxford), 2005; 44: 1483–1491.

  14. Biggioggero M, Crotti C, et al: The management of acute anterior uveitis complicating spondyloarthritis: present and future. Biomed Res Int, 2018; 14: 9460187.

  15. Khan MA, Mathieu A, et al: The pathogenetic role of HLA–B27 and its subtypes.Autoimmun Rev, 2007; 6: 183–189.

  16. Ball J: Enthesopathy of rheumatoid and ankylosing spondylitis. Ann Rheum Dis, 1971; 30: 213–223.

  17. Ehrenfeld M. Best Pract Res Clin Rheumatol, 2012; 26: 135–145.

  18. Taurog JD, Richardson JA, et al: The germfree state prevents development of gut and joint inflammatory disease in HLA–B27 transgenic rats. J Exp Med, 1994; 180: 2359–2364.

  19. Wei JCC, Tsai WC, et al: HLA–B60 and B61 are strongly associated with ankylosing spondylitis in HLA–B27–negative Taiwan Chiese patients. Rheumatology, 2004; 43: 839–842

  20. Carli L, Calabresi E, et al: One year in review 2018: axial spondyloarthritis. Clin Exp Rheumatol, 2019; 37: 889–898.

  21. Pedersen SJ, Maksymowych WP: The pathogenesis of ankylosing spondylitis: an update. Curr Rheumatol Rep, 2019; 21: 58.

  22. Taylor W, Gladman D, et al: CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum, 2006; 54: 2665–2673.

  23. Rudwaleit M, Khan MA, et al: The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum. 2005; 52: 1000–1008.

  24. Carvalho PD, Machado PM: How to investigate: early axial spondyloarthritis. Best Pract Res Clin Rheumatol, 2019; 33: 101427.

  25. Reijnierse M, Landewé R, et al: ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)–cohort and from the Assessment of SpondyloArthritis international Society (ASAS)–cohort. Ann Rheum Dis, 2013; 72: 1646–1653.

  26. van der Heijde D, Ramiro S, et al: 2016 update of the ASAS–EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis, 2017; 76: 978–999.

  27. Dagfinrud H, Hagen KB, et al: Physiotherapy interventions for ankylosing spondylitis, Coch Database Syst Rev, 2008; 2008: CD002822.

  28. 大槻マミ太郎，佐伯秀久，他：乾癬における生物学的製剤の使用ガイダンス (2019年版)，日本皮膚科学会雑誌，2019: 129, 1845–1864.